Label: UREA 39% CREAM cream

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated March 6, 2024

If you are a consumer or patient please visit this version.

  • GENERAL:

    This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.

  • DESCRIPTION

    This product is a keratolytic emollient which is a gentle, yet potent, tissue softener for skin.

    Each gram contains 390 mg of urea in a vehicle consisting of: carbomer, cetyl alcohol, dimethyl isosorbide, glyceryl stearate, mineral oil, petrolatum, propylene glycol, sodium hydroxide, water, and xanthan gum.

    Urea is a diamide of carbonic acid with the following chemical structure:

    Structure

  • CLINICAL PHARMACOLOGY

    Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

  • PHARMACOKINETICS

    The mechanism of action of topically applied urea is not yet known.

  • INDICATIONS:

    This product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.

  • CONTRAINDICATIONS

    This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

  • WARNINGS

    KEEP OUT OF REACH OF CHILDREN.

  • PRECAUTIONS

    FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

  • INFORMATION FOR PATIENTS

    Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or
    elsewhere. Avoid contact with eyes, lips and mucous membranes.

  • CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

    Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.

  • PREGNANCY

    Category C.Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.

  • NURSING MOTHERS

    It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

  • ADVERSE REACTIONS

    Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.

  • DOSAGE & ADMINISTRATION

    Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.

  • STORAGE AND HANDLING

    Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to
    temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

  • NOTICE:

    Protect from freezing and excessive heat. Keep bottle tightly closed.

  • HOW SUPPLIED

    8 oz. (227 g) bottles, NDC 44523-801-08

  • SPL UNCLASSIFIED SECTION

    To reporta serious adverse event or obtain product information, call (866) 762-2365.

    Manufactured for:
    BIOCOMP PHARMA, INC.
    San Antonio, TX 78230 1355


    2100669 [00] R1021

  • PRINCIPAL DISPLAY PANEL

    BCP UREA 39% Cream

  • INGREDIENTS AND APPEARANCE
    UREA 39% CREAM 
    urea 39% cream cream
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:44523-801
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    UREA (UNII: 8W8T17847W) (UREA - UNII:8W8T17847W) UREA390 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    MINERAL OIL (UNII: T5L8T28FGP)  
    PETROLATUM (UNII: 4T6H12BN9U)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    DIMETHYL ISOSORBIDE (UNII: SA6A6V432S)  
    CARBOMER INTERPOLYMER TYPE A (55000 CPS) (UNII: 59TL3WG5CO)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:44523-801-08227 g in 1 BOTTLE; Type 0: Not a Combination Product09/23/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other09/23/2022
    Labeler - BioComp Pharma, Inc. (829249718)
    Establishment
    NameAddressID/FEIBusiness Operations
    Mission Pharmacal Company927726893manufacture(44523-801)